Comorbidity clusters and their relationship with severity and outcomes of index diseases, in a large multicentre systemic lupus erythematosus cohort
Open Access
- 1 July 2025
- journal article
- research article
- Published by BMJ in Lupus Science & Medicine
- Vol. 12 (2) , e001633
Abstract
Objective: Patients with SLE have a well-known increased risk of major comorbidities, although they are also very heterogeneous in terms of the prevalence of comorbid conditions. The relationships of such comorbidities with the outcomes and the severity of index diseases are less known. We aimed to evaluate the interactions between comorbid conditions, in a large multicentre SLE cohort, and their impact on severity and outcomes, using a cluster analysis. Methods: Data on 14 cumulative comorbidities were derived from patients with SLE (American College of Rheumatology (ACR)-97 criteria) who had been included in the retrospective phase of the RELESSER (Spanish Society of Rheumatology National Register of SLE). The Severity Katz Index and the SLICC/ACR Damage Index were calculated. Unsupervised cluster analysis was performed to better characterise the relationships between comorbidities in a large multicentre cohort of patients with SLE. For intercluster differences testing, analysis of variance and Tukey tests were used to compare continuous numerical variables; a Kruskal-Wallis test to discrete variables and the χ² (or Fisher’s exact test) were used for categorical ones. Results: A total of 3658 patients with SLE were included. Men accounted for 9.6% of patients. The mean (SD) age was 45.9 years, and 93% were Caucasian. Four clusters, with markedly different comorbidity profiles and outcomes, were identified: in cluster 2 (n=516), patients were grouped around depression (100% of the cases); in cluster 3 (n=418) around serious infections (100%); and in cluster 4 (n=388) around cardiovascular events (also 100%). However, in cluster 1, the largest one (n=2336), no patient had any of the three defining comorbidities of the other clusters, and this cluster was associated with the best outcomes. Conclusions: Cluster analysis identifies well-differentiated subsets of patients with SLE in terms of their comorbidities. The most relevant comorbidities in SLE tend to aggregate in the most severe patient subsets.Keywords
Funding Information
- Spanish Foundation of Rheumatology
This publication has 26 references indexed in Scilit:
- Predictors of infection requiring hospitalization in patients with systemic lupus erythematosus: a time-to-event analysisSeminars in Arthritis and Rheumatism, 2022
- Explore comorbidities associated with systemic lupus erythematosus: a total population-based case–control studyQJM: An International Journal of Medicine, 2020
- Relationship between damage and mortality in juvenile-onset systemic lupus erythematosus: Cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER)Seminars in Arthritis and Rheumatism, 2019
- Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosusSeminars in Arthritis and Rheumatism, 2017
- The evolving concept of SLE comorbiditiesExpert Review of Clinical Immunology, 2017
- Burden of Comorbidity in Systemic Lupus Erythematosus in the UK, 1999–2012Arthritis Care & Research, 2016
- Registro nacional de pacientes con lupus eritematoso sistémico de la Sociedad Española de Reumatología: objetivos y metodologíaReumatología Clínica, 2014
- Relationship between autoantibody clustering and clinical subsets in SLE: cluster and association analyses in Hong Kong ChineseRheumatology, 2012
- Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?Arthritis & Rheumatism, 2005
- Excess mortality in depression: a meta-analysis of community studiesJournal of Affective Disorders, 2002